A mass spectrometer from Thermo Fisher Scientific, Inc. has been chosen by the Institut de Recherches Cliniques de Montreal (ICRM) for use in their proteomics research approach that could impact the current understanding of the human proteome.
A mass spectrometer from Thermo Fisher Scientific, Inc. has been chosen by the Institut de Recherches Cliniques de Montreal (ICRM) for use in their proteomics research approach that could impact the current understanding of the human proteome.
Dr. Benoit Coulombe, his research team at ICRM, and collaborators in various universities and research centers are conducting the research project, called the Human Proteotheque Initiative (HuPI). The overall goal of the project is to define the maps of protein interactions that regulate cell growth, differentiation, and disease progression. Central to the project is its experimental platform, including the LTQ Orbitrap linear ion trap mass spectrometer, which generates maps of protein interaction networks.
This information potentially can lead to future groundbreaking discoveries of new molecular tools for the prevention and treatment of disease.
"What is most important is to develop a highly reliable and efficient discovery pipeline that generates interaction maps that are both as complete and as accurate as possible. The specificity of our procedure to identify functionally relevant interaction partners is spectacular," said Dr. Coulombe.
Targeted Blood Lipidomics of Colorectal Cancer: An HTC-18 Interview with Jef Focant
July 26th 2024At HTC-18 in Leuven, Executive Editor of LCGC International, Alasdair Matheson, spoke to Jef Focant from the University of Liege about his talk entitled, “Targeted Blood Lipidomics of Colorectal Cancer."
Carol Robinson Awarded 2024 Lifetime Achievement European Inventor Award
July 24th 2024Carol Robinson of the University of Oxford has received the European Inventor Award 2024 for Lifetime Achievement from the European Patent Office for her work bringing mass spectrometry to structural biology.